When a medical device is software‑only and intended to support clinical trial operations, the FDA classifies it...
post-market surveillance
Securing reimbursement for a digital therapeutic in the European Union requires more than meeting the Medical Device...
The rise of continuous‑learning AI and self‑updating digital health tools has forced regulators and manufacturers to rethink...
Living Algorithms are software systems that continue to learn and adapt after market release; designing continuous real‑world...